SK Bioscience Co Ltd (302440) — Cash Flow Reinvestment Rate
SK Bioscience Co Ltd (302440) has a Cash Flow Reinvestment Rate of 4.95x as of September 2025, reinvesting ₩102.27 Billion (capex ₩70.94 Billion plus investments ₩-31.32 Billion) from operating cash flow of ₩20.65 Billion. Explore SK Bioscience Co Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SK Bioscience Co Ltd Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for SK Bioscience Co Ltd across 5 annual periods. Also explore SK Bioscience Co Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for SK Bioscience Co Ltd (2018–2023)
Year-by-year capital reinvestment analysis for SK Bioscience Co Ltd. For live market cap and broader valuation context, see market cap of SK Bioscience Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 3.26x | ₩95.57 Billion | ₩29.35 Billion | ₩50.30 Billion | ▲ +22.4% |
| 2021 | 2.66x | ₩1.43 Trillion | ₩536.59 Billion | ₩42.91 Billion | ▲ +184.7% |
| 2020 | 0.93x | ₩112.32 Billion | ₩120.22 Billion | ₩9.93 Billion | ▼ -45.0% |
| 2019 | 1.70x | ₩37.06 Billion | ₩21.82 Billion | ₩23.97 Billion | ▲ +5.7% |
| 2018 | 1.61x | ₩23.95 Billion | ₩14.90 Billion | ₩6.31 Billion | — |